2306 related articles for article (PubMed ID: 8102131)
1. Reduced expression of nm23-H1, but not of nm23-H2, is concordant with the frequency of lymph-node metastasis of human breast cancer.
Tokunaga Y; Urano T; Furukawa K; Kondo H; Kanematsu T; Shiku H
Int J Cancer; 1993 Aug; 55(1):66-71. PubMed ID: 8102131
[TBL] [Abstract][Full Text] [Related]
2. nm23--relationship to the metastatic potential of breast carcinoma cell lines, primary human xenografts, and lymph node negative breast carcinoma patients.
Russell RL; Geisinger KR; Mehta RR; White WL; Shelton B; Kute TE
Cancer; 1997 Mar; 79(6):1158-65. PubMed ID: 9070493
[TBL] [Abstract][Full Text] [Related]
3. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
[TBL] [Abstract][Full Text] [Related]
4. Altered expression of nm23-H1 and c-erbB-2 proteins have prognostic significance in adenocarcinoma but not in squamous cell carcinoma of the uterine cervix.
Mandai M; Konishi I; Koshiyama M; Komatsu T; Yamamoto S; Nanbu K; Mori T; Fukumoto M
Cancer; 1995 May; 75(10):2523-9. PubMed ID: 7736397
[TBL] [Abstract][Full Text] [Related]
5. Nm-23, c-erbB-2, and progesterone receptor expression in invasive breast cancer: correlation with clinicopathologic parameters.
Nakopoulou LL; Tsitsimelis D; Lazaris AC; Tzonou A; Gakiopoulou H; Dicoglou CC; Davaris PS
Cancer Detect Prev; 1999; 23(4):297-308. PubMed ID: 10403901
[TBL] [Abstract][Full Text] [Related]
6. NM23 gene expression in human breast carcinomas: loss of correlation with cell proliferation in the advanced phase of tumor progression.
Caligo MA; Cipollini G; Berti A; Viacava P; Collecchi P; Bevilacqua G
Int J Cancer; 1997 Feb; 74(1):102-11. PubMed ID: 9036878
[TBL] [Abstract][Full Text] [Related]
7. Analysis of nm23-H1 expression in breast cancer. Correlation with p53 expression and clinicopathologic findings.
Dueñas-González A; Abad-Hernández MM; García-Mata J; Paz-Bouza JI; Cruz-Hernández JJ; González-Sarmiento R
Cancer Lett; 1996 Mar; 101(2):137-42. PubMed ID: 8620461
[TBL] [Abstract][Full Text] [Related]
8. Expression of nm23-H1 gene and Sialyl Lewis X antigen in breast cancer.
Yamaguchi A; Ding K; Maehara M; Goi T; Nakagawara G
Oncology; 1998; 55(4):357-62. PubMed ID: 9663428
[TBL] [Abstract][Full Text] [Related]
9. Expression of metastasis-associated genes h-mts1 (S100A4) and nm23 in carcinoma of breast is related to disease progression.
Albertazzi E; Cajone F; Leone BE; Naguib RN; Lakshmi MS; Sherbet GV
DNA Cell Biol; 1998 Apr; 17(4):335-42. PubMed ID: 9570150
[TBL] [Abstract][Full Text] [Related]
10. Nm23 gene product expression in invasive breast cancer--immunohistochemical analysis and clinicopathological correlation.
Belev B; Alerić I; Vrbanec D; Petrovecki M; Unusic J; Jakić-Razumović J
Acta Oncol; 2002; 41(4):355-61. PubMed ID: 12234027
[TBL] [Abstract][Full Text] [Related]
11. Nm23 expression in endometrial and cervical cancer: inverse correlation with lymph node involvement and myometrial invasion.
Marone M; Scambia G; Ferrandina G; Giannitelli C; Benedetti-Panici P; Iacovella S; Leone A; Mancuso S
Br J Cancer; 1996 Oct; 74(7):1063-8. PubMed ID: 8855975
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of Nm23/NDPK expression in breast carcinoma, assessed on 10-year follow-up by automated and quantitative immunocytochemical assays.
Charpin C; Garcia S; Bonnier P; Martini F; Andrac L; Horschowski N; Lavaut MN; Allasia C
J Pathol; 1998 Apr; 184(4):401-7. PubMed ID: 9664906
[TBL] [Abstract][Full Text] [Related]
13. NDP-K/nm23 expression in human breast cancer in relation to relapse, survival, and other prognostic factors: an immunohistochemical study.
Sawan A; Lascu I; Veron M; Anderson JJ; Wright C; Horne CH; Angus B
J Pathol; 1994 Jan; 172(1):27-34. PubMed ID: 7931824
[TBL] [Abstract][Full Text] [Related]
14. [Expression of nm23 in breast cancer: correlation with distant metastasis and prognosis].
Liu H; Mao H; Fu X
Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):224-7. PubMed ID: 11783092
[TBL] [Abstract][Full Text] [Related]
15. MMTV-associated transcription factor binding sites increase nm23-H1 metastasis suppressor gene expression in human breast carcinoma cell lines.
Ouatas T; Clare SE; Hartsough MT; De La Rosa A; Steeg PS
Clin Exp Metastasis; 2002; 19(1):35-42. PubMed ID: 11918081
[TBL] [Abstract][Full Text] [Related]
16. High levels of nm23-H1 and nm23-H2 messenger RNA in human squamous-cell lung carcinoma are associated with poor differentiation and advanced tumor stages.
Engel M; Theisinger B; Seib T; Seitz G; Huwer H; Zang KD; Welter C; Dooley S
Int J Cancer; 1993 Sep; 55(3):375-9. PubMed ID: 8375920
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneous expression of nm23 gene product as a predictor of lymph nodal status in human breast cancer.
Yoshida H; Kijima H; Terasaki Y; Suto A; Takeshita T; Omiya H; Shimojima K; Shimbori M; Sato T; Sato S; Onoda N; Yamazaki H; Tamaoki N; Ueyama Y; Nakamura M
Int J Oncol; 1998 Dec; 13(6):1141-6. PubMed ID: 9824622
[TBL] [Abstract][Full Text] [Related]
18. [Study on expression of nm23-H1 gene in laryngeal cancer tissues].
Wang Q; Guo M; Sun L
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1996; 31(4):198-200. PubMed ID: 9642340
[TBL] [Abstract][Full Text] [Related]
19. C-erbB-2, p53, and nm23 gene product expression in breast cancer in young women: immunohistochemical analysis and clinicopathologic correlation.
Bertheau P; Steinberg SM; Merino MJ
Hum Pathol; 1998 Apr; 29(4):323-9. PubMed ID: 9563780
[TBL] [Abstract][Full Text] [Related]
20. Analysis of oncogenes and tumor suppressor genes in human breast cancer.
Yamashita H; Kobayashi S; Iwase H; Itoh Y; Kuzushima T; Iwata H; Itoh K; Naito A; Yamashita T; Masaoka A
Jpn J Cancer Res; 1993 Aug; 84(8):871-8. PubMed ID: 8104920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]